NYSE:TEVA
Teva Pharmaceutical (TEVA)
Financials 
Technical Analysis 
Aug 4, 2026, 12:00 amThis summary was created by AI, based on 4 opinions in the last 12 months.
Teva Pharmaceutical (TEVA-N) has garnered mixed reviews from various experts, reflecting a dynamic yet cautious outlook on its performance. In recent months, the stock has significantly appreciated, showing a 264% increase since early 2023 under the leadership of its current CEO. Despite this positive trajectory, experts express concerns regarding the erosion of prices in the GLP market as more generics come into play, which could impact Teva's profitability. While it has exhibited strong momentum and accumulated growth since breaking the $21 mark in September, there's skepticism about its level of innovation in an increasingly competitive pharmaceutical landscape. Analysts project a bullish target price of $34.50, underlining potential optimism despite the caveats presented in the commentary.
The demand of GLP remains strong, but as more generics enter the market, the prices of the GLPs will go down. If you bet on Teva, you expects GLP demand to remain strong. GLP will come in pill shape, and there will be more amazing drug discoveries. However, Teva isn't a very innovative company. He avoids pharma; it's too hard to determine who will be a winner.
HQ is in Israel. Large-cap pharma. Right now, #1-ranked in his ADR/CDR universe (international stocks with American/Canadian Depositary Receipts). We've seen rotation into drug stocks. Broke out over $21 in September and has kept right on going. Very strong accumulation for about 6 months now. No dividend.
(Analysts’ price target is $34.50)
Colin Cieszynski
'%20fill='%23ffffff'%3e%3cg%20id='Pager'%20transform='translate(423.000000,%201755.000000)'%3e%3cpath%20d='M243.295367,17.286474%20C243.68919,16.9045087%20244.327703,16.9045087%20244.721525,17.286474%20L249,21.4361302%20L253.278475,17.286474%20C253.672297,16.9045087%20254.31081,16.9045087%20254.704633,17.286474%20C255.098456,17.6684393%20255.098456,18.2877274%20254.704633,18.6696927%20L249.35654,23.856763%20C249.159628,24.0477457%20248.840372,24.0477457%20248.64346,23.856763%20L243.295367,18.6696927%20C242.901544,18.2877274%20242.901544,17.6684393%20243.295367,17.286474%20Z'%20id='Path'%20transform='translate(249.000000,%2020.500000)%20rotate(-90.000000)%20translate(-249.000000,%20-20.500000)%20'%3e%3c/path%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
Popular Articles
Teva Pharmaceutical (TEVA) Frequently Asked Questions
What is Teva Pharmaceutical stock symbol?
Teva Pharmaceutical is a American stock, trading under the symbol TEVA (previously TEVA-N on Stockchase) on the New York Stock Exchange (TEVA). It is usually referred to as NYSE:TEVA or TEVA
Is Teva Pharmaceutical a buy or a sell?
In the last year, 4 stock analysts issued a Buy, Sell, or Hold rating on TEVA (previously TEVA-N on Stockchase). 3 analysts recommended to BUY and 1 analyst recommended to SELL the stock. The latest stock analyst rating is PAST TOP PICK. Read the latest stock experts' ratings for Teva Pharmaceutical.
Is Teva Pharmaceutical a good investment or a top pick?
Teva Pharmaceutical was recommended as a Top Pick by Colin Cieszynski on 2026-07-15. Read the latest stock experts ratings for Teva Pharmaceutical.
Why is Teva Pharmaceutical stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Teva Pharmaceutical.
Is Teva Pharmaceutical worth watching?
Teva Pharmaceutical is followed by 70 investors on Stockchase and is a trending stock that is worth watching.
What is Teva Pharmaceutical stock price?
On 2026-08-04, Teva Pharmaceutical (TEVA) stock closed at a price of $34.43.
'%20fill='%23FFB800'%3e%3cg%20id='filled-.-button'%20transform='translate(120.000000,%20413.999972)'%3e%3cpath%20d='M101.499729,2.82302245e-05%20C102.285413,-0.00432461793%20103.254164,0.496634241%20103.645655,1.25173399%20L103.712109,1.39623206%20L105.747863,6.45331817%20L111.028779,6.80428588%20C111.60867,6.84282525%20112.147242,7.1236355%20112.517275,7.58038413%20C113.223405,8.45199453%20113.142035,9.72214747%20112.357105,10.4940033%20L112.234099,10.6059323%20L108.072656,14.10894%20L109.356339,19.592529%20C109.472157,20.0872738%20109.394126,20.6085551%20109.13883,21.0455786%20C108.624329,21.9263208%20107.536956,22.2447485%20106.649713,21.8010736%20L106.511398,21.7246573%20L101.5,18.7715858%20L96.4886024,21.7246573%20C95.5790916,22.2767096%2094.4027498,21.9726757%2093.8611695,21.0455786%20C93.6058745,20.6085551%2093.5278433,20.0872738%2093.6436608,19.592529%20L94.9273443,14.10894%20L90.7659013,10.6059323%20C89.8680707,9.85015912%2089.7412886,8.49557505%2090.4827254,7.58038413%20C90.8527577,7.1236355%2091.39133,6.84282525%2091.9712215,6.80428588%20L97.2521374,6.45331817%20L99.2878908,1.39623206%20C99.6240254,0.561228427%20100.665516,-0.00460395016%20101.499729,2.82302245e-05%20Z'%20id='top-picks-.-icon-copy-7'%3e%3c/path%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/svg%3e){kind=small}
'%20fill='%23EAEAEA'%3e%3cg%20id='filled-.-button'%20transform='translate(120.000000,%20413.999972)'%3e%3cpath%20d='M131.499729,2.82302245e-05%20C132.285413,-0.00432461793%20133.254164,0.496634241%20133.645655,1.25173399%20L133.712109,1.39623206%20L135.747863,6.45331817%20L141.028779,6.80428588%20C141.60867,6.84282525%20142.147242,7.1236355%20142.517275,7.58038413%20C143.223405,8.45199453%20143.142035,9.72214747%20142.357105,10.4940033%20L142.234099,10.6059323%20L138.072656,14.10894%20L139.356339,19.592529%20C139.472157,20.0872738%20139.394126,20.6085551%20139.13883,21.0455786%20C138.624329,21.9263208%20137.536956,22.2447485%20136.649713,21.8010736%20L136.511398,21.7246573%20L131.5,18.7715858%20L126.488602,21.7246573%20C125.579092,22.2767096%20124.40275,21.9726757%20123.86117,21.0455786%20C123.605874,20.6085551%20123.527843,20.0872738%20123.643661,19.592529%20L124.927344,14.10894%20L120.765901,10.6059323%20C119.868071,9.85015912%20119.741289,8.49557505%20120.482725,7.58038413%20C120.852758,7.1236355%20121.39133,6.84282525%20121.971221,6.80428588%20L127.252137,6.45331817%20L129.287891,1.39623206%20C129.624025,0.561228427%20130.665516,-0.00460395016%20131.499729,2.82302245e-05%20Z'%20id='top-picks-.-icon-copy-8'%3e%3c/path%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/svg%3e){kind=small}
(Note the short timeframe.) Healthcare and drug sectors have been strong, so this should have done better. Reasonably high in the RSI index, it's OK, he still owns.